Guizhou Sanli Pharmaceutical Co., Ltd. Class ASSE: 603439

Announcement on the Company's and Its Holding Subsidiary's Application for Comprehensive Credit Lines from Banks in 2025

· Issued by Guizhou Sanli Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Company's and Its Holding Subsidiary's Application for Comprehensive Credit Lines from Banks in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment